Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

PURPOSE: To assess efficacy and safety of a new dry powder formulation of inhaled colistimethate sodium in patients with cystic fibrosis (CF) aged ≥6 years with chronic Pseudomonas aeruginosa lung infection. STUDY DESIGN AND METHODS: A prospective, centrally randomised, phase III, open-label study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuster, Antje, Haliburn, Cynthia, Döring, Gerd, Goldman, Martin Harris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595146/
https://www.ncbi.nlm.nih.gov/pubmed/23135343
http://dx.doi.org/10.1136/thoraxjnl-2012-202059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595146/
https://www.ncbi.nlm.nih.gov/pubmed/23135343
http://dx.doi.org/10.1136/thoraxjnl-2012-202059

Ejemplares similares